Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBD Wellness News: BoxScore Pivots To CBD, Shineco, Datong JV, More

Executive Summary

Endo Water researches Kansas; CannAmerica new packages, gummy flavors shipping; Profile's Elite brand blooms CBD Flower; NeutriSci, Falcon plan sublingual CBD tablet; Aleafia distributed metered-dose cannabis spray; Plus launches Classic Mint, makes CFO switch; BoxScore Brands pivots to CBD focus with new CEO; and Shineco, Datong JV for hemp supplement chain, DBD development.

You may also be interested in...



Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials

Australia Relaxes Competition Rules To Facilitate Coronavirus Response

Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.

Interview: Izana Tests GM-CSF Drug For Coronavirus

The UK biotech's CEO tells Scrip that Izana's objective is to treat rapidly deteriorating COVID-19 patients before ICU admission and prior to ventilation.

Topics

UsernamePublicRestriction

Register

RS148747

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel